Tuesday 11 June 2013 – Economic Tribune
Pharmaceutical exports from India increased by 10.55 percent in 2012-13 to reach $14.6 billion. The US remained the top export destination for pharmaceuticals in 2013, with $3.7 billion,
against 3.2 billion dollars in 2012 followed by UK at $ 511,000,000 against $ 491,000,000 in the previous budget. Exports recorded a 25 percent growth in local currency terms at INR 79.4 trillion versus INR 63.5 trillion during 2011-12.
India has a 15 percent share of US generics by volume. Over 550 manufacturing sites and over 3,000 drugs are registered with the USFDA. India's share of drugs registered is nearly 40 percent of those filed with the USFDA.
This growth by the Indian pharmaceutical industry reflects the strong fundamentals of the sector. In the coming years, India's pharmaceutical industry is expected to continue growing at a rate of at least 20 percent. (ICE MUMBAI)
